Docetaxol
Download report
Favorite
Events Timeline
Commercial
Clinical
Drug
Target
Variants
Financial
Trends
Safety
Events Timeline
5D
1M
3M
6M
YTD
1Y
2Y
5Y
Max
Events
FDA approval date
EMA approval date
Patent expiration date
Study first post date
Last update post date
Start date
Primary completion date
Completion date
Results first post date
Mock data
Subscribe for the real data
Subscribe for the real data
Commercial
No data
Clinical
Clinical Trials
3159 clinical trials
View more details
Mock data
Subscribe for the real data
Subscribe for the real data
Indications Phases 4
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Breast neoplasms | D001943 | EFO_0003869 | C50 | 88 | 375 | 214 | 27 | 81 | 733 |
| Non-small-cell lung carcinoma | D002289 | — | — | 134 | 380 | 160 | 8 | 32 | 635 |
| Prostatic neoplasms | D011471 | — | C61 | 120 | 274 | 92 | 5 | 49 | 483 |
| Neoplasms | D009369 | — | C80 | 203 | 119 | 31 | 2 | 19 | 328 |
| Lung neoplasms | D008175 | — | C34.90 | 52 | 189 | 53 | 3 | 20 | 284 |
| Stomach neoplasms | D013274 | EFO_0003897 | C16 | 37 | 150 | 40 | 1 | 21 | 216 |
| Squamous cell carcinoma of head and neck | D000077195 | — | — | 39 | 103 | 30 | 1 | 4 | 153 |
| Head and neck neoplasms | D006258 | — | — | 35 | 80 | 13 | 2 | 7 | 123 |
| Adenocarcinoma | D000230 | — | — | 14 | 85 | 21 | 1 | 8 | 121 |
| Neoplasm metastasis | D009362 | EFO_0009708 | — | 32 | 61 | 28 | 1 | 10 | 117 |
Show 14 more
Indications Phases 3
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Carcinoma | D002277 | — | C80.0 | 16 | 57 | 26 | — | 12 | 103 |
| Ovarian neoplasms | D010051 | EFO_0003893 | C56 | 29 | 51 | 14 | — | 6 | 93 |
| Nasopharyngeal carcinoma | D000077274 | — | — | 3 | 28 | 26 | — | 13 | 67 |
| Nasopharyngeal neoplasms | D009303 | — | — | 3 | 31 | 21 | — | 13 | 65 |
| Ovarian epithelial carcinoma | D000077216 | — | — | 16 | 28 | 10 | — | 3 | 53 |
| Pancreatic neoplasms | D010190 | EFO_0003860 | C25 | 17 | 37 | 2 | — | 2 | 51 |
| Sarcoma | D012509 | — | — | 21 | 31 | 6 | — | 1 | 50 |
| Urinary bladder neoplasms | D001749 | — | C67 | 14 | 28 | 10 | — | 4 | 49 |
| Esophageal squamous cell carcinoma | D000077277 | — | — | 8 | 22 | 17 | — | 4 | 47 |
| Recurrence | D012008 | — | — | 7 | 27 | 12 | — | 2 | 45 |
Show 90 more
Indications Phases 2
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Colorectal neoplasms | D015179 | — | — | 21 | 15 | — | — | 2 | 26 |
| Melanoma | D008545 | — | — | 13 | 10 | — | — | 1 | 19 |
| Liver neoplasms | D008113 | EFO_1001513 | C22.0 | 2 | 6 | — | — | 1 | 9 |
| Biliary tract neoplasms | D001661 | — | C24.9 | 3 | 7 | — | — | 1 | 8 |
| Lymphoma | D008223 | — | C85.9 | 6 | 2 | — | — | — | 7 |
| Hepatocellular carcinoma | D006528 | — | C22.0 | 2 | 4 | — | — | — | 6 |
| Thyroid neoplasms | D013964 | EFO_0003841 | — | 3 | 3 | — | — | — | 6 |
| Malignant pleural effusion | D016066 | — | J91.0 | 1 | 5 | — | — | — | 6 |
| Kidney neoplasms | D007680 | EFO_0003865 | C64 | 4 | 2 | — | — | 1 | 6 |
| Gallbladder neoplasms | D005706 | EFO_0004606 | C23 | 2 | 2 | — | — | 1 | 5 |
Show 124 more
Indications Phases 1
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Non-hodgkin lymphoma | D008228 | — | C85.9 | 3 | — | — | — | — | 3 |
| B-cell chronic lymphocytic leukemia | D015451 | — | C91.1 | 2 | — | — | — | — | 2 |
| Pharmacokinetics | D010599 | — | — | 1 | — | — | — | 1 | 2 |
| Hematologic neoplasms | D019337 | — | — | 2 | — | — | — | — | 2 |
| Kaposi sarcoma | D012514 | — | C46 | 2 | — | — | — | — | 2 |
| Parotid neoplasms | D010307 | EFO_0003873 | C07 | 1 | — | — | — | — | 1 |
| Medical sociology | D012962 | — | — | 1 | — | — | — | — | 1 |
| Thrombocytopenia | D013921 | HP_0001873 | D69.6 | 1 | — | — | — | — | 1 |
| Connective and soft tissue neoplasms | D018204 | — | — | 1 | — | — | — | — | 1 |
| Paraneoplastic syndromes | D010257 | — | — | 1 | — | — | — | — | 1 |
Show 27 more
Indications Without Phase
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Lymphedema | D008209 | — | Q82.0 | — | — | — | — | 2 | 2 |
| Malnutrition | D044342 | EFO_0008572 | E40-E46 | — | — | — | — | 2 | 2 |
| Carcinogenesis | D063646 | — | — | — | — | — | — | 1 | 1 |
| Methylation | D008745 | — | — | — | — | — | — | 1 | 1 |
| Bone fractures | D050723 | EFO_0003931 | T14.8 | — | — | — | — | 1 | 1 |
| Covid-19 | D000086382 | — | U07.1 | — | — | — | — | 1 | 1 |
| Breast cancer lymphedema | D000072656 | — | — | — | — | — | — | 1 | 1 |
| Taste disorders | D013651 | — | — | — | — | — | — | 1 | 1 |
| Dysgeusia | D004408 | — | R43.2 | — | — | — | — | 1 | 1 |
| Ageusia | D000370 | EFO_1001758 | — | — | — | — | — | 1 | 1 |
Show 21 more
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
| Drug common name | — |
| INN | — |
| Description | — |
| Classification | Unknown |
| Drug class | — |
| Image (chem structure or protein) |  |
| Structure (InChI/SMILES or Protein Sequence) | — |
Identifiers
| PDB | — |
| CAS-ID | — |
| RxCUI | — |
| ChEMBL ID | — |
| ChEBI ID | — |
| PubChem CID | — |
| DrugBank | — |
| UNII ID | — |
Target
No data
Variants
No data
Financial
No data
Trends
No data
Safety
Black-box Warning
No Black-box warning
Adverse Events
Top Adverse Reactions
Mock data
Subscribe for the real data
Subscribe for the real data
25 adverse events reported
View more details
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use